2016;21:150–155; first published on January 19, 2016; http://dx.doi:10.1634/theoncologist.2015-0312The online version of this article has been amended to correct errors that appear in Table 1 on page 152. A row was added to the “Treatment” section to provide missing MDH treatment data. In the “Histologic grade” section, the percentage noted for “GX” in the “pCR = no” column was incorrect; the correct percentage is 73.3. An errant comma in the “G3” heading was removed. For clarity, the heading of the last row of the table was changed to read “Ki67, median (range), %”.
Authors: Xin Zhang; Dong Ren; Ling Guo; Lan Wang; Shu Wu; Chuyong Lin; Liping Ye; Jinrong Zhu; Jun Li; Libing Song; Huanxin Lin; Zhenyu He Journal: Breast Cancer Res Date: 2017-02-08 Impact factor: 6.466
Authors: Milos Holanek; Iveta Selingerova; Ondrej Bilek; Tomas Kazda; Pavel Fabian; Lenka Foretova; Maria Zvarikova; Radka Obermannova; Ivana Kolouskova; Oldrich Coufal; Katarina Petrakova; Marek Svoboda; Alexandr Poprach Journal: Cancers (Basel) Date: 2021-03-30 Impact factor: 6.639